Kither Biotech logo

Kither Biotech jobs and careers

Torino, Italy

About Kither Biotech

Kither Biotech is a pharmaceutical product company that focuses its R&D activities on the development of new drugs. The R&D activities of the company mainly involve the development of new drugs to treat chronic inflammatory diseases.In recent years Kither has focused its first line of activities on the development of a small peptide(KIT2014) developed internally for the treatment of cystic fibrosis, a disease that predominantly affects the lungs and that currently has no cure. The KIT2014 peptide was assigned the Orphan Drug designation from the European Medicines Agency. The KIT2014 compound is currently undergoing the pre-clinical phase of clinical development.Kither’s product portfolio also includes a molecule (CL27), also developed internally, that is being developed for the treatment of Chronic Obstructive Pulmonary Diseases and Allergic Asthma. The company is about to start the pre-clinical phase of development of the CL27 molecule.

Founded in 2018 by Emilio Hirsch and Marco Kevin Malisani.

Founded
2018
Employees
1 to 10
Total funding
$24.1M
Headquarters
Torino

Leadership

The top of Kither Biotech's org chart, with how many people report into each leader.

VSPhoto of Valentina Sala

Valentina Sala

Head of Scientific Affairs

1 report

AGPhoto of Alessandra Ghigo

Alessandra Ghigo

Co-founder and Shareholder

CUPhoto of Carla Uslenghi

Carla Uslenghi

Chief Medical Officer

EHPhoto of Emilio Hirsch

Emilio Hirsch

Founder

SVPhoto of Svetlana Vashkel

Svetlana Vashkel

Non-Executive Director

DGPhoto of Dimitrios Goundis

Dimitrios Goundis

Chief Executive Officer

MMPhoto of Marco Kevin Malisani

Marco Kevin Malisani

Co-founder and Executive Director

JBPhoto of Janki Bhatt

Janki Bhatt

Research Associate I

Jobs at Kither Biotech

No open positions right now. Explore more companies on TheJobsMap.